The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Induction of Macrophage Foam Cell Formation by Chlamydia pneumoniae
Abstract
Foam cell formation is the hallmark of early atherosclerosis. It was found that the intracellular bacterium Chlamydia pneumoniae induces foam cell formation by human monocyte-derived macrophages. Exposure of macrophages to C. pneumoniae followed by low-density lipoprotein (LDL) caused a marked increase in the number of foam cells and accumulation of cholesteryl esters. Foam cell formation was not inhibited by the antioxidant butylated hydroxytoluene nor fucoidan, suggesting that lipid accumulation did not involve scavenger receptors. In contrast, addition of heparin, which blocks binding of LDL to the LDL receptor, inhibited C. pneumoniae-induced foam cell formation, suggesting that the pathogen induced lipid accumulation by dysregulating native LDL uptake or metabolism (or both). These data demonstrate that an infectious agent can induce macrophage foam cell formation and implicate C. pneumoniae as a causative factor in atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
Esterbauer, H., Gebicki, J., Puhl, H., & Jürgens, G. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90181-f · Cited by 2,306
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
Separation of plasma lipoproteins by density-gradient ultracentrifugation
Redgrave, T. G., Roberts, D. C. K., & West, C. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90488-1 · Cited by 1,107
Caldwell, H. D., Kromhout, J. P., & Schachter, J. (1981) · Infection and Immunity · doi:10.1128/iai.31.3.1161-1176.1981 · Cited by 1,053
The Role of Lipids and Lipoproteins in Atherosclerosis
Gofman, J. W., Lindgren, F., Elliott, H., Mantz, W., Hewitt, J., Strisower, B., Herring, V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 918
Mendall, M. A., Patel, P., Ballam, L., Strachan, D., & Northfield, T. C. (1996) · BMJ · doi:10.1136/bmj.312.7038.1061 · Cited by 846
Interaction of chlamydiae and host cells in vitro
Moulder, J. W. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.1.143-190.1991 · Cited by 820
Cited by
Foamy macrophages and the progression of the human tuberculosis granuloma
Russell, D. G., Cardona, P.-J., Kim, M.-J., Allain, S., & Altare, F. (2009) · Nature Immunology · doi:10.1038/ni.1781 · Cited by 827
Xu, X. H., Shah, P. K., Faure, E., Equils, O., Thomas, L., Fishbein, M. C., Luthringer, D., Xu, X.-P., Rajavashisth, T. B., Yano, J., et al. (2001) · Circulation · doi:10.1161/hc5001.100631 · Cited by 666
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
Infection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Monocyte recruitment and foam cell formation in atherosclerosis
Bobryshev, Y. V. (2006) · Micron · doi:10.1016/j.micron.2005.10.007 · Cited by 374
Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis
Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W., & Meyer, J. (2002) · Circulation · doi:10.1161/hc0102.101362 · Cited by 338
Hu, H., Pierce, G. N., & Zhong, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4582 · Cited by 297
<EMPH TYPE="ITAL">Chlamydia pneumoniae</EMPH> as an Emerging Risk Factor in Cardiovascular Disease
Kalayoglu, M. V. (2002) · JAMA · doi:10.1001/jama.288.21.2724 · Cited by 283
Self-citationBackground and Current Knowledge of Chlamydia pneumoniae and Atherosclerosis
Grayston, J. T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315596 · Cited by 281
Chlamydia pneumoniae — an infectious risk factor for atherosclerosis?
Campbell, L. A., & Kuo, C.-C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro796 · Cited by 277
Heat Shock Proteins, Inflammation, and Cardiovascular Disease
Pockley, A. G. (2002) · Circulation · doi:10.1161/hc0802.103729 · Cited by 264
Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion
Carabeo, R. A., Mead, D. J., & Hackstadt, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131289100 · Cited by 263
Kalayoglu, M. V., Bula, D., Arroyo, J., Gragoudas, E. S., D’Amico, D., & Miller, J. W. (2005) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-1169-y · Cited by 86
Self-citationThe lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Metadata
- Authors
- Kalayoglu, M. V., & Byrne, G. I.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-03
- Volume
- 177
- Issue
- 3
- Pages
- 725-729
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2109663336
- Cited by
- 275
- References
- 23
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.